Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Long-Term Remission After Hematopoietic Stem Cell Transplantation for Refractory Cutaneous T Cell Lymphoma

John P. Galvin, MD, MPH, Joanne Monreal, Joan Guitart, MD, Steve T. Rosen, MD, Timothy Kuzel, MD, Jayesh Mehta, MD

Blood (2012) 120 (21): 2028.

https://doi.org/10.1182/blood.V120.21.2028.2028

Published: 2012

Journal Articles

Phase II Multicenter Trial of Lenalidomide: Clinical and Immunomodulatory Effects in Patients with CTCL

Christiane Querfeld, MD, PhD, Steven T. Rosen, MD, Joan Guitart, MD, Madeleine Duvic, MD, Youn H. Kim, MD, Charles Goolsby, PhD, Timothy Kuzel, MD

Blood (2011) 118 (21): 1638.

https://doi.org/10.1182/blood.V118.21.1638.1638

Published: 2011

Journal Articles

Efficacy of Extracorporeal Photopheresis (ECP) Monotherapy in the Treatment of Cutaneous T Cell Lymphoma.

Larisa Geskin, MD, FAAD, Francine Foss, MD, Madeleine Duvic, MD, David Straus, MD, Steven Horwitz, MD, Jasmine Zain, MD, Timothy Kuzel, MD, Christiane Querfeld, MD, Kim Campbell, PhD, Robert Knobler, MD

Blood (2007) 110 (11): 2561.

https://doi.org/10.1182/blood.V110.11.2561.2561

Published: 2007

Journal Articles

Phase II Preliminary Results of SGN-30 (Anti-CD30 mAb) in Patients with CD30+ Lymphoproliferative Disorders.

Madeleine Duvic, MD, Youn Kim, MD, Sunil Reddy, MD, Andres Forero-Torres, MD, Lauren C. Pinter-Brown, MD, Mark U. Rarick, MD, John Zic, MD, Sophie Worobec, MD, Neil Korman, MD, Timothy Kuzel, MD, Kimberly Bohjanen, MD, Karen Flessland, Jeremy Barton, MD, Eric Sievers, MD

Blood (2006) 108 (11): 2733.

https://doi.org/10.1182/blood.V108.11.2733.2733

Published: 2006

Journal Articles

TLR9 Agonist Immunomodulator Treatment of Cutaneous T-Cell Lymphoma (CTCL) with CPG7909.

Youn Kim, MD, Michael Girardi, MD, Madeline Duvic, MD, Timothy Kuzel, MD, Alain Rook, MD, Brian Link, MD, Lauren Pinter-Brown, MD, Carol Comerci, Sonja McAuley, Tess Schmalbach, MD

Blood (2004) 104 (11): 743.

https://doi.org/10.1182/blood.V104.11.743.743

Published: 2004

Journal Articles

Severe Gemcitabine-Associated Lung Injury in Hodgkins Disease & Other Cancers: Reporting Quality and Clinical Characteristics of Cases Reported in the Medical Literature and to the FDA.

Steven M. Belknap, MD, Nicolas Slimack, BA, Timothy Kuzel, MD, Kenneth R. Carson, MD, Paul R. Yarnold, PhD, Dennis W. Raisch, PhD, Steven M. Trifilio, PharmD, Charles L. Bennett, MD

Blood (2004) 104 (11): 3145.

https://doi.org/10.1182/blood.V104.11.3145.3145

Published: 2004

NARROW

Long-Term Remission After Hematopoietic Stem Cell Transplantation for Refractory Cutaneous T Cell Lymphoma

Phase II Multicenter Trial of Lenalidomide: Clinical and Immunomodulatory Effects in Patients with CTCL

Efficacy of Extracorporeal Photopheresis (ECP) Monotherapy in the Treatment of Cutaneous T Cell Lymphoma.

Phase II Preliminary Results of SGN-30 (Anti-CD30 mAb) in Patients with CD30+ Lymphoproliferative Disorders.

TLR9 Agonist Immunomodulator Treatment of Cutaneous T-Cell Lymphoma (CTCL) with CPG7909.

Severe Gemcitabine-Associated Lung Injury in Hodgkins Disease & Other Cancers: Reporting Quality and Clinical Characteristics of Cases Reported in the Medical Literature and to the FDA.

Email alerts

ASH Publications

American Society of Hematology

Long-Term Remission After Hematopoietic Stem Cell Transplantation for Refractory Cutaneous T Cell Lymphoma

Phase II Multicenter Trial of Lenalidomide: Clinical and Immunomodulatory Effects in Patients with CTCL

Efficacy of Extracorporeal Photopheresis (ECP) Monotherapy in the Treatment of Cutaneous T Cell Lymphoma.

Phase II Preliminary Results of SGN-30 (Anti-CD30 mAb) in Patients with CD30+ Lymphoproliferative Disorders.

TLR9 Agonist Immunomodulator Treatment of Cutaneous T-Cell Lymphoma (CTCL) with CPG7909.

Severe Gemcitabine-Associated Lung Injury in Hodgkins Disease & Other Cancers: Reporting Quality and Clinical Characteristics of Cases Reported in the Medical Literature and to the FDA.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only